Report from the 24th Annual Western Canadian Gastrointestinal Cancer Consensus Conference on Colorectal Cancer, Richmond, British Columbia, 28-29, October 2022

Sharlene Gill; Shahid Ahmed; Brady Anderson; Scott Berry; Howard Lim; Terry Phang; Ankur Sharma; Joao Paulo Solar Vasconcelos; Karamjit Gill; Mussawar Iqbal; Keith Tankel; Theresa Chan; Magdalena Recsky; Jennifer Nuk; James Paul; Shazia Mahmood

doi:10.3390/curroncol30090579

Report from the 24th Annual Western Canadian Gastrointestinal Cancer Consensus Conference on Colorectal Cancer, Richmond, British Columbia, 28-29, October 2022

Curr Oncol. 2023 Aug 29;30(9):7964-7983. doi: 10.3390/curroncol30090579.

Authors

Affiliations

¹ British Columbia Cancer Agency, Vancouver, BC V5Z 4E6, Canada.
² Saskatchewan Cancer Agency, Saskatoon, SK S4W 0G3, Canada.
³ Western Manitoba Cancer Center, Brandon, MB R7A 5M8, Canada.
⁴ Department of Oncology, Queen's University, Kingston, ON K7L 3N6, Canada.
⁵ Department of Surgery, University of British Columbia, Vancouver, BC V6T 1Z4, Canada.
⁶ Central Alberta Cancer Centre, School of Medicine, University of Calgary Cumming, Red Deer, AB T4N 6R2, Canada.
⁷ Allan Blair Cancer Centre, Regina, SK S4T 7T1, Canada.
⁸ Cross Cancer Institute, Edmonton, AB T6G 1Z2, Canada.
⁹ British Columbia Cancer Agency, Surrey, BC V3V 1Z2, Canada.
¹⁰ Kelowna General Hospital, Kelowna, BC V1Y 1T2, Canada.
¹¹ British Columbia Cancer Hereditary Cancer Program, Victoria, BC V8R 6V5, Canada.
¹² CancerCare Manitoba, University of Manitoba, Winnipeg, MB R3E 0V9, Canada.

Abstract

The 24th annual Western Canadian Gastrointestinal Cancer Consensus Conference (WCGCCC) was held in Richmond, British Columbia, on 28-29 October 2022. The WCGCCC is an interactive multidisciplinary conference attended by healthcare professionals from across Western Canada (British Columbia, Alberta, Saskatchewan, and Manitoba) who are involved in the care of patients with gastrointestinal cancer. Surgical, medical, and radiation oncologists; pathologists; radiologists; and allied health care professionals such as dieticians, nurses and a genetic counsellor participated in presentation and discussion sessions for the purpose of developing the recommendations presented here. This consensus statement addresses current issues in the management of colorectal cancer.

Keywords: adjuvant chemotherapy; colon cancer; colorectal cancer; immunotherapy; molecular tests; rectal cancer; surgery.

Publication types

Congress

Grants and funding

The 2023 WCGCCC received unrestricted educational grants from Pfizer, Eisai, Amgen, Astellas Pharma, Incyte Corporation, Merck & Co., Taiho Pharmaceutical, BeiGene, Bristol Myers Squibb, and AstraZeneca. During the entire process, sponsors had no influence whatsoever over the development of the guidelines, and they did not review or read the guidelines before submission. No author was compensated for their work on this article.